歡迎來(lái)到北京博奧森生物技術(shù)有限公司網(wǎng)站！歡迎來(lái)到北京博奧森生物技術(shù)有限公司網(wǎng)站！
18611424007
當(dāng)前位置：首頁(yè) > 產(chǎn)品中心 > 抗體/抗原 > 一抗 > bsm-62352R二氫嘧啶脫氫酶重組兔單抗
簡(jiǎn)要描述：Dihydropyrimidine dehydrogenase (DPYD) catalyzes the first rate-limiting step of the NADPH-dependent catabolism of uracil and thymine to dihydrouracil and dihydrothymine; thus, a deficiency of DPYD leads to an accumulation of uracil and thymine. Abnormal concentrations of these metabolites in bodily fluids may be the cause of neurological disease and a contraindication for treatment of cancer patients with certain pyrimidine analogs. DPYD also catalyzes the anticancer agent 5-fluorouracil (
產(chǎn)品型號(hào)：bsm-62352R廠商性質(zhì)：生產(chǎn)廠家更新時(shí)間：2025-03-03訪 問(wèn) 量： 138產(chǎn)品分類
Product Category相關(guān)文章
Related Articles詳細(xì)介紹
產(chǎn)品咨詢
網(wǎng)站首頁(yè)